Correlation Between Allovir and Radcom

Can any of the company-specific risk be diversified away by investing in both Allovir and Radcom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allovir and Radcom into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Allovir and Radcom, you can compare the effects of market volatilities on Allovir and Radcom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allovir with a short position of Radcom. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allovir and Radcom.

Diversification Opportunities for Allovir and Radcom

-0.7

Correlation Coefficient

Allovir  Radcom

Excellent diversification

The 3 months correlation between Allovir and Radcom is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Allovir and Radcom in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Radcom and Allovir is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allovir are associated (or correlated) with Radcom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Radcom has no effect on the direction of Allovir i.e., Allovir and Radcom go up and down completely randomly.

Pair Corralation between Allovir and Radcom

Given the investment horizon of 90 days Allovir is expected to under-perform the Radcom. In addition to that, Allovir is 1.6 times more volatile than Radcom. It trades about -0.1 of its total potential returns per unit of risk. Radcom is currently generating about -0.01 per unit of volatility. If you would invest  1,240  in Radcom on October 5, 2024 and sell it today you would lose (25.00) from holding Radcom or give up 2.02% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Allovir  vs.  Radcom

Allovir

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Allovir has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Radcom

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Radcom are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Radcom displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Allovir and Radcom

The main advantage of trading using opposite Allovir and Radcom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allovir position performs unexpectedly, Radcom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Radcom will offset losses from the drop in Radcom's long position.

The idea behind Allovir and Radcom pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.